Exploring the intricate landscape of cardiac lipidomics, this dynamic field delves into the intricate world of lipid molecules within the cardiovascular system. As crucial components of cell membranes, lipids play an essential role in shaping cellular structure and functionality. In the realm of cardiac health, lipidomics extends its reach to comprehensively study the lipid composition of cardiac tissues, shedding light on their multifaceted roles in both physiological equilibrium and pathological disruptions. By unraveling the complexities of the heart's lipidomic profile, researchers gain valuable insights into lipid metabolism, signaling pathways, and their implications for various cardiac conditions, ranging from atherosclerosis to heart failure. Utilizing cutting-edge analytical techniques, experts in cardiac lipidomics strive to characterize diverse lipid species, opening avenues for innovative diagnostic tools and therapeutic interventions to tackle cardiovascular disorders. This fusion of lipid biochemistry and cardiology not only offers a deeper understanding of cardiac lipidomics but also holds the potential to uncover novel biomarkers and therapeutic targets, fostering advancements in cardiovascular medicine.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States